CSF and Serum Biomarkers of Cerebral Damage in Autoimmune Epilepsy
Introduction: Our goal was to investigate whether biomarkers of cerebral damage are found in autoimmune-mediated epilepsy (AIE) and whether these can differentiate AIE from other seizure disorders.Methods: We retrospectively searched our cerebrospinal fluid (CSF) database for patients with definite...
Main Authors: | Robert Daniel Nass, Katja Akgün, Karmele Olaciregui Dague, Christian Erich Elger, Heinz Reichmann, Tjalf Ziemssen, Rainer Surges |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-04-01
|
Series: | Frontiers in Neurology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fneur.2021.647428/full |
Similar Items
-
CSF Neurofilament Light Chain Elevation Predicts ALS Severity and Progression
by: Qionghua Sun, et al.
Published: (2020-08-01) -
Neurofilament Proteins as Biomarkers to Monitor Neurological Diseases and the Efficacy of Therapies
by: Aidong Yuan, et al.
Published: (2021-09-01) -
Natalizumab Pharmacokinetics and -Dynamics and Serum Neurofilament in Patients With Multiple Sclerosis
by: Undine Proschmann, et al.
Published: (2021-04-01) -
CSF Neurofilament Light Chain Levels in Primary Progressive MS: Signs of Axonal Neurodegeneration
by: Marc Pawlitzki, et al.
Published: (2018-12-01) -
Increased Neurofilament Light Chain and YKL-40 CSF Levels in One Japanese IBMPFD Patient With VCP R155C Mutation: A Clinical Case Report With CSF Biomarker Analyses
by: Masaki Ikeda, et al.
Published: (2020-08-01)